Genentech
HERCEPTIN
Manufacturer:
Genentech
Name:
HERCEPTIN
HCPCS Code Descriptor:
Injection, trastuzumab, excludes biosimilar, 10 mg
Category:
J Code
HCPCS:
J9355
NDC(s):
50242-0132-01, 50242-0132-10
Primary Type:
Oncology
Generic Status:
Single-Source
Route of Administration:
Intravenous
About:
HERCEPTIN is an Oncology drug manufactured by Genentech and administered via the Intravenous route of administration. The J Code: J9355 is aligned to the drug HERCEPTIN.
Access Pricing and More By Registering
HCPCS Added Date:
1/1/00
HCPCS Effective Date:
7/1/19
HCPCS Short Description:
Inj trastuzumab excl biosimi
Billing and Coding Guide:
https://www.genentech-access.com/content/dam/gene/accesssolutions/pdfs/coding/Herceptin-Billing-Coding-for-Metastatic-Gastric-Cancer.pdf, https://www.genentech-access.com/content/dam/gene/accesssolutions/pdfs/coding/Herceptin-Billing-Coding-for-FL-SL-TL-Metastatic-Breast-Cancer.pdf
Patient Assistance:
https://www.gene.com/patients/patient-foundation
